A BILL 
To require the Secretary of Health and Human Services 
to award targeted grants to State, Tribal, Territorial, 
and local health departments or nonprofit organizations 
in geographic locations with racial and ethnic minorities 
and other vulnerable populations disproportionately im-
pacted by COVID–19 to disseminate information regard-
ing the safety and efficacy of COVID–19 vaccines, and 
for other purposes. 
23:03 Mar 20, 2021
H1268
2 
•HR 1268 IH
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Building COVID–19 
4
Vaccine Confidence Act of 2021’’. 
5
SEC. 2. HEALTH DISPARITY-INFORMED COVID–19 VACCINE 
6
SAFETY AND EFFICACY PUBLIC AWARENESS 
7
CAMPAIGN GRANTS. 
8
(a) IN GENERAL.—The Secretary of Health and 
9
Human Services (referred to in this section as the ‘‘Sec-
10
retary’’), acting through the Director of the Centers for 
11
Disease Control and Prevention and in coordination with 
12
the Deputy Assistant Secretary for Minority Health and, 
13
as appropriate, with the directors of the relevant Offices 
14
of Minority health of the Department of Health and 
15
Human Services, the Director of the National Institute on 
16
Minority Health and Health Disparities, and the Director 
17
of the Indian Health Service, shall award grants to eligible 
18
entities to carry out evidence-based campaigns to dissemi-
19
nate COVID–19 vaccination information. 
20
(b) ELIGIBLE ENTITIES.—To be eligible to receive a 
21
grant under this section, an entity shall— 
22
(1) be a State, Tribal, Territorial, or local 
23
health department, an Urban Indian organization 
24
(as defined in section 4 of the Indian Health Care 
25
23:03 Mar 20, 2021
H1268
3 
•HR 1268 IH
Improvement Act (25 U.S.C. 1603)), a nonprofit 
1
community-based organization, or a nonprofit faith- 
2
based organization; and 
3
(2) submit an application to the Secretary at 
4
such time, in such manner, and containing such in-
5
formation as the Secretary may require, including 
6
demographic data on the entity’s COVID–19 vaccine 
7
campaign target. 
8
(c) USE
OF FUNDS.—Entities receiving a grant 
9
under this section shall use such grant funds to— 
10
(1) create multilingual and culturally appro-
11
priate messaging to disseminate scientific and evi-
12
dence-based information related to COVID–19 vac-
13
cines; 
14
(2) provide information on where the COVID– 
15
19 vaccine can be obtained; 
16
(3) target racial and ethnic minority commu-
17
nities; 
18
(4) target communities with a COVID–19 Com-
19
munity Vulnerability Index higher than the national 
20
average; 
21
(5) increase awareness and knowledge of the 
22
safety and effectiveness of vaccines approved or au-
23
thorized by the Food and Drug Administration for 
24
23:03 Mar 20, 2021
H1268
4 
•HR 1268 IH
the prevention and control of COVID–19 and the 
1
benefit of receiving a COVID–19 vaccine; 
2
(6) increase awareness and knowledge of 
3
COVID–19, including countering stigma associated 
4
with COVID–19; 
5
(7) address vaccine skepticism in communities 
6
of color; 
7
(8) address COVID–19 vaccine misinformation; 
8
(9) address side effects after COVID–19 vac-
9
cination; 
10
(10) share information on the processes and 
11
policies that lead to vaccine development, licensure, 
12
manufacturing, and recommendations for use; and 
13
(11) other matters the Secretary determines 
14
necessary. 
15
(d) PROHIBITION ON DISCRIMINATION.—Programs 
16
funded under this section shall not discriminate on the 
17
basis of actual or perceived sex, race, color, ethnicity, na-
18
tional origin, disability, sexual orientation, gender identity, 
19
or religion. Nothing in this section shall be construed to 
20
invalidate or limit rights, remedies, procedures, or legal 
21
standards available under any other Federal law or any 
22
law of a State or a political subdivision of a State, includ-
23
ing the Civil Rights Act of 1964 (42 U.S.C. 2000a et 
24
seq.), title IX of the Education Amendments of 1972 (20 
25
23:03 Mar 20, 2021
H1268
5 
•HR 1268 IH
U.S.C. 1681 et seq.), section 504 of the Rehabilitation Act 
1
of 1973 (29 U.S.C. 794), the Americans with Disabilities 
2
Act of 1990 (42 U.S.C. 12101 et seq.), and section 1557 
3
of the Patient Protection and Affordable Care Act (42 
4
U.S.C. 18116). 
5
(e) REPORT TO CONGRESS.—Not later than 45 days 
6
after the date on which appropriated funds are made avail-
7
able to the Secretary under this section, the Secretary 
8
shall submit to Congress a report on how such funds have 
9
been used during such 45-day period and a plan for using 
10
any remaining funds within the next 45 days. 
11
(f) EVALUATION.—The Secretary shall— 
12
(1) conduct qualitative assessments regarding 
13
the campaign under this section; and 
14
(2) not later than one year after the date of en-
15
actment of this Act, prepare and submit to the Com-
16
mittee on Appropriations and the Committee on 
17
Health, Education, Labor, and Pensions of the Sen-
18
ate and the Committee on Appropriations and the 
19
Committee on Energy and Commerce of the House 
20
of Representatives an evaluation of the campaign 
21
under this section. 
22
(g) RULE OF CONSTRUCTION.—Nothing in this Act 
23
shall be construed to limit an eligible entity from receiving 
24
23:03 Mar 20, 2021
H1268
6 
•HR 1268 IH
a grant under this section for a population otherwise 
1
served by such organization with other Federal funds. 
2
(h) PRIORITIZATION.—In awarding grants under 
3
subsection (a), the Secretary shall give special consider-
4
ation to eligible entities that have demonstrated a commit-
5
ment to a targeted campaign to reach communities where 
6
the greatest health disparities have been identified with 
7
respect to testing access and rates of infections, hos-
8
pitalizations, and deaths related to COVID–19. 
9
(i) AUTHORIZATION OF APPROPRIATIONS.—There is 
10
authorized to be appropriated to carry out this section 
11
$50,000,000 for fiscal year 2022. 
12
Æ 
23:03 Mar 20, 2021
H1268
